Ravenquest Biomed Stock Analysis
Ravenquest Biomed is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Ravenquest Biomed pink sheet analysis is to determine its intrinsic value, which is an estimate of what Ravenquest Biomed is worth, separate from its market price. There are two main types of Ravenquest Biomed's stock analysis: fundamental analysis and technical analysis.
The Ravenquest Biomed pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Ravenquest Biomed's ongoing operational relationships across important fundamental and technical indicators.
Ravenquest |
Ravenquest Pink Sheet Analysis Notes
The company has price-to-book ratio of 0.03. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Ravenquest Biomed recorded a loss per share of 0.22. The entity had not issued any dividends in recent years. RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada. RAVENQUEST BIOMED operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange.The quote for Ravenquest Biomed is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Ravenquest Biomed contact George Robinson at 877-282-1586 or learn more at https://www.rqbglobal.com.Ravenquest Biomed Investment Alerts
| Ravenquest Biomed generated a negative expected return over the last 90 days | |
| Ravenquest Biomed has some characteristics of a very speculative penny stock | |
| The company has a current ratio of 0.48, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ravenquest Biomed until it has trouble settling it off, either with new capital or with free cash flow. So, Ravenquest Biomed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ravenquest Biomed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ravenquest to invest in growth at high rates of return. When we think about Ravenquest Biomed's use of debt, we should always consider it together with cash and equity. | |
| Ravenquest Biomed reported the revenue of 1.26 M. Net Loss for the year was (30.47 M) with profit before overhead, payroll, taxes, and interest of 801.29 K. | |
| Ravenquest Biomed has accumulated about 749.13 K in cash with (11.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Ravenquest Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 48.21 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ravenquest Biomed's market, we take the total number of its shares issued and multiply it by Ravenquest Biomed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Ravenquest Biomed, as well as the relationship between them.Ravenquest Biomed Price Movement Analysis
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was four with a total number of output elements of fifty-seven. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Ravenquest Biomed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Ravenquest Biomed. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Ravenquest Biomed Outstanding Bonds
Ravenquest Biomed issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ravenquest Biomed uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ravenquest bonds can be classified according to their maturity, which is the date when Ravenquest Biomed has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
About Ravenquest Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Ravenquest Biomed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ravenquest shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Ravenquest Biomed. By using and applying Ravenquest Pink Sheet analysis, traders can create a robust methodology for identifying Ravenquest entry and exit points for their positions.
RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada. RAVENQUEST BIOMED operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Ravenquest Biomed to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Complementary Tools for Ravenquest Pink Sheet analysis
When running Ravenquest Biomed's price analysis, check to measure Ravenquest Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ravenquest Biomed is operating at the current time. Most of Ravenquest Biomed's value examination focuses on studying past and present price action to predict the probability of Ravenquest Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ravenquest Biomed's price. Additionally, you may evaluate how the addition of Ravenquest Biomed to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |